Petra Duda

Petra Duda has a diverse work experience spanning over several companies and roles. Petra is currently working as a Global Development Lead at UCB since April 2020. Prior to this, Petra held positions at Ra Pharmaceuticals as an Executive Director of Clinical Research and Senior Director of Clinical Research from 2017 to 2019. Petra also worked as a Medical Director at Sarepta Therapeutics from 2013 to 2017 and as a Director of Medical Research at Biogen from 2011 to 2013. Additionally, Petra worked as an Associate Director of Medical Research at Biogen Idec from 2007 to 2010. Petra started their career as a Resident at Hospital Chur in 2006 and then served as a Chief Resident at Rehabilitation Clinic Valens from 2004 to 2006. Petra also worked as a Staff Scientist, Project Leader, and Resident at University Hospital Basel from 1999 to 2004. Their earlier experience includes working as a Scientific Advisor at Boehringer Ingelheim from 2000 to 2002 and as a Postdoctoral Fellow at Harvard Medical School from 1997 to 1999.

Petra Duda earned an MD PhD degree in Medicine and Biology from the University of Bern, attending from 1984 to 1990.